tlooto
Sign up
Open AccessMedicineChemistry

Actinium-225 in targeted alpha-particle therapeutic applications.

D. Scheinberg, M. McDevitt

2011.9.30Current Radiopharmaceuticals

DOI: 10.2174/1874471011104040306

tlooto Summary

Alpha particle-emitting isotopes are being investigated in radioimmunotherapeutic applications because of their unparalleled cytotoxicity when targeted to cancer and their relative lack of toxicity towards untargeted normal tissue.

Abstract

Abstract is not available.

Citation format

SCHEINBERG, D.; MCDEVITT, M. Actinium-225 in targeted alpha-particle therapeutic applications. Current Radiopharmaceuticals, 2011, 4 4: 306–20.